Literature DB >> 8641698

Localization of the human vascular endothelial growth factor gene, VEGF, at chromosome 6p12.

M H Wei1, N C Popescu, M I Lerman, M J Merrill, D B Zimonjic.   

Abstract

Using overlapping cosmids representing the vascular endothelial growth factor (VEGF) locus, the VEGF gene was mapped by fluorescence in situ hybridization to chromosome 6p12. This localization permits linkage analysis and the identification of gene interaction in the region, as well as alterations of the VEGF structure or expression in cancer cells with chromosome abnormalities.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8641698

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


  17 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth.

Authors:  M S O'Reilly; L Holmgren; Y Shing; C Chen; R A Rosenthal; Y Cao; M Moses; W S Lane; E H Sage; J Folkman
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1994

3.  Chromosomal mapping of the human histone gene H2AZ to 4q24 by fluorescence in situ hybridization.

Authors:  N Popescu; D Zimonjic; C Hatch; W Bonner
Journal:  Genomics       Date:  1994-03-15       Impact factor: 5.736

4.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing.

Authors:  E Tischer; R Mitchell; T Hartman; M Silva; D Gospodarowicz; J C Fiddes; J A Abraham
Journal:  J Biol Chem       Date:  1991-06-25       Impact factor: 5.157

5.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.

Authors:  G H Fong; J Rossant; M Gertsenstein; M L Breitman
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

6.  Localization of the human cholecystokinin-B/gastrin receptor gene (CCKBR) to chromosome 11p15.5-->p15.4 by fluorescence in situ hybridization.

Authors:  D B Zimonjic; N C Popescu; T Matsui; M Ito; K Chihara
Journal:  Cytogenet Cell Genet       Date:  1994

7.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.

Authors:  D Shweiki; A Itin; D Soffer; E Keshet
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

8.  Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

Authors:  R A Berkman; M J Merrill; W C Reinhold; W T Monacci; A Saxena; W C Clark; J T Robertson; I U Ali; E H Oldfield
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

Review 9.  Vascular permeability factor (VPF, VEGF) in tumor biology.

Authors:  D R Senger; L Van de Water; L F Brown; J A Nagy; K T Yeo; T K Yeo; B Berse; R W Jackman; A M Dvorak; H F Dvorak
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

Review 10.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440
View more
  8 in total

1.  What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis?

Authors:  R F Nicosia
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

2.  VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression.

Authors:  M L George; M G Tutton; F Janssen; A Arnaout; A M Abulafi; S A Eccles; R I Swift
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

3.  Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.

Authors:  Asish K Ghosh; Charla R Secreto; Traci R Knox; Wei Ding; Debabrata Mukhopadhyay; Neil E Kay
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

4.  The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity.

Authors:  Przemko Kwinta; Mirosław Bik-Multanowski; Zofia Mitkowska; Tomasz Tomasik; Jacek J Pietrzyk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-11       Impact factor: 3.117

5.  VEGF silencing inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via PI3K/AKT signaling pathway.

Authors:  Jian Zhao; Zi-Ru Zhang; Na Zhao; Bao-An Ma; Qing-Yu Fan
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 6.  Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration.

Authors:  Chandrakumar Balaratnasingam; Elona Dhrami-Gavazi; Jesse T McCann; Quraish Ghadiali; K Bailey Freund
Journal:  Clin Ophthalmol       Date:  2015-12-17

7.  Relationship of common variants in VEGFA gene with osteonecrosis of the femoral head: A Han Chinese population based association study.

Authors:  Wenlong Ma; Kun Xin; Ke Chen; Hongtao Tang; Honggan Chen; Liqiang Zhi; Hongliang Liu
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

Review 8.  Is There a Genetic Predisposition to Postoperative Adhesion Development?

Authors:  Mili Thakur; Anupama Rambhatla; Farnoosh Qadri; Charalampos Chatzicharalampous; Modupe Awonuga; Ghassan Saed; Michael P Diamond; Awoniyi O Awonuga
Journal:  Reprod Sci       Date:  2020-10-22       Impact factor: 3.060
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.